Regulatory Expertise 3D Communications specializes in preparing for high-stakes interactions with US and EU regulators, policymakers, payers, and investors. This positions the company to offer regulated industry communications and market access strategy services to pharma, biotech, and medical device clients seeking to navigate compliance and approvals.

Science to Story Leveraging the 3D ACT process to translate complex scientific data into clear, persuasive messaging and presentations creates opportunities to upsell narrative development, visual communication, and regulatory submission support for drug and device programs.

Growth Readiness With a revenue range of 50 to 100 million and a mid-sized team, 3D is well-positioned to pursue mid-market pharma and biotech accounts for expanded advisory services, including market access strategy, payer communications, and stakeholder engagement programs.

Tech Enablement Existing tech stack including WordPress, Salesforce, and marketing automation suggests opportunities to offer digital transformation, CRM-led account-based marketing, and data-driven outreach services aligned with client onboarding and ongoing engagement.

Competitive Positioning Operating in a market with large PR firms, 3D can differentiate on scientific credibility, regulatory know-how, and specialized market access expertise, making it a compelling partner for sponsors seeking regulated communications and payer-focused strategies.